Logo for Gelesis Holdings Inc

Gelesis Investor Relations Material

Latest events

Logo for Gelesis

Q2 2023

14 Aug, 2023
Logo for Gelesis

Q1 2023

15 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Gelesis Holdings Inc is a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation.